CAPR - Capricor Therapeutics GAAP EPS of -$0.31 beats by $0.01 revenue of $2.98M beats by $2.48M May, 11 2023 04:03 PM Capricor Therapeutics Inc. 2023-05-11 16:03:01 ET Capricor Therapeutics press release ( NASDAQ: CAPR ): Q1 GAAP EPS of -$0.31 beats by $0.01 . Revenue of $2.98M beats by $2.48M . For further details see: Capricor Therapeutics GAAP EPS of -$0.31 beats by $0.01, revenue of $2.98M beats by $2.48M